Results 61 to 70 of about 54,609 (148)

All Inkjet-Printed EL-QD Display with Cd Free QD Inks

open access: yesProceedings of the International Display Workshops, 2023
Masanobu Tanaka   +4 more
openaire   +1 more source

Once-daily oral ritlecitinib or brepocitinib versus placebo in patients with moderate-to-severely active Crohn's disease (PIZZICATO): an international, randomised, phase 2a trial. [PDF]

open access: yesEClinicalMedicine
Vermeire S   +16 more
europepmc   +1 more source

Imatinib and nilotinib are equally successful in achieving therapy-free remission. [PDF]

open access: yesBlood Cancer J
Cheng F   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy